StockNews.com started coverage on shares of Dynatronics (NASDAQ:DYNT – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Stock analysts at StockNews.com initiated coverage on shares of Dynatronics (NASDAQ:DYNT – Get Free Report) in a report released on Saturday. The brokerage set a “hold” rating on the medical equipment ...

Lumbosacral radiculopathy is a neurologic condition that occurs when a nerve root in the lower back is compressed or irritated. Millions of patients suffer from pain due to LSR every year.

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

Vertex Pharmaceuticals Incorporated VRTX announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip ...

announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip that radiates down the back of the thigh ...

Vertex Pharmaceuticals shares sank Thursday after the company reported mixed results in a Phase 2 drug trial to treat ...

Hoping to show the drug’s versatility, Vertex also sponsored a mid-stage trial focused on painful “lumbosacral radiculopathy, ...

It's also evaluating the drug in a phase 3 study for treating diabetic peripheral neuropathic pain, and a phase 2 study for treating lumbosacral radiculopathy (lower back and hip pain).

The S&P 500 slipped 0.1% on Thursday, Dec. 19, 2024, as stocks struggled to recover from the prior day's sell-off despite upbeat data on economic growth.

His posts often had a communal support undercurrent ... In a thread where another user asked for advice about surgery on the lumbosacral joint known as L5-S1, the username tied to Mangione ...